BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 23167835)

  • 1. Effect of galactooligosaccharides and Bifidobacterium animalis Bb-12 on growth of Lactobacillus amylovorus DSM 16698, microbial community structure, and metabolite production in an in vitro colonic model set up with human or pig microbiota.
    Martinez RC; Cardarelli HR; Borst W; Albrecht S; Schols H; Gutiérrez OP; Maathuis AJ; de Melo Franco BD; De Martinis EC; Zoetendal EG; Venema K; Saad SM; Smidt H
    FEMS Microbiol Ecol; 2013 Apr; 84(1):110-23. PubMed ID: 23167835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of gastrointestinal survival of Lactobacillus amylovorus DSM 16698 alone and combined with galactooligosaccharides, milk and/or Bifidobacterium animalis subsp. lactis Bb-12.
    Martinez RC; Aynaou AE; Albrecht S; Schols HA; De Martinis EC; Zoetendal EG; Venema K; Saad SM; Smidt H
    Int J Food Microbiol; 2011 Sep; 149(2):152-8. PubMed ID: 21741105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro fermentation of prebiotic carbohydrates by intestinal microbiota in the presence of Lactobacillus amylovorus DSM 16998.
    Cardarelli HR; Martinez RC; Albrecht S; Schols H; Franco BD; Saad SM; Smidt H
    Benef Microbes; 2016 Feb; 7(1):119-133. PubMed ID: 26615853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acerola (Malpighia glabra L.) and guava (Psidium guayaba L.) industrial processing by-products stimulate probiotic Lactobacillus and Bifidobacterium growth and induce beneficial changes in colonic microbiota.
    Menezes FNDD; de Melo FHC; Vieira ARS; Almeida ÉTC; Lima MS; Aquino JS; Gomez-Zavaglia A; Magnani M; de Souza EL
    J Appl Microbiol; 2021 Apr; 130(4):1323-1336. PubMed ID: 32808408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
    Saarela M; Maukonen J; von Wright A; Vilpponen-Salmela T; Patterson AJ; Scott KP; Hämynen H; Mättö J
    Int J Antimicrob Agents; 2007 Mar; 29(3):271-80. PubMed ID: 17207972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a (13)C-labeling technique.
    Maathuis AJ; van den Heuvel EG; Schoterman MH; Venema K
    J Nutr; 2012 Jul; 142(7):1205-12. PubMed ID: 22623395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07.
    Larsen N; Vogensen FK; Gøbel R; Michaelsen KF; Abu Al-Soud W; Sørensen SJ; Hansen LH; Jakobsen M
    FEMS Microbiol Ecol; 2011 Mar; 75(3):482-96. PubMed ID: 21204871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults.
    Davis LM; Martínez I; Walter J; Hutkins R
    Int J Food Microbiol; 2010 Dec; 144(2):285-92. PubMed ID: 21059476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prebiotic Galactooligosaccharide Metabolism by Probiotic Lactobacilli and Bifidobacteria.
    Thongaram T; Hoeflinger JL; Chow J; Miller MJ
    J Agric Food Chem; 2017 May; 65(20):4184-4192. PubMed ID: 28466641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
    Krumbeck JA; Rasmussen HE; Hutkins RW; Clarke J; Shawron K; Keshavarzian A; Walter J
    Microbiome; 2018 Jun; 6(1):121. PubMed ID: 29954454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
    Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
    J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study.
    Roessler A; Forssten SD; Glei M; Ouwehand AC; Jahreis G
    Clin Nutr; 2012 Feb; 31(1):22-9. PubMed ID: 21963389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial composition and in vitro fermentation patterns of human milk oligosaccharides and prebiotics differ between formula-fed and sow-reared piglets.
    Li M; Bauer LL; Chen X; Wang M; Kuhlenschmidt TB; Kuhlenschmidt MS; Fahey GC; Donovan SM
    J Nutr; 2012 Apr; 142(4):681-9. PubMed ID: 22399522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of composition and metabolic activities of the colonic microflora of growing pigs fed diets supplemented with prebiotic oligosaccharides.
    Mountzouris KC; Balaskas C; Fava F; Tuohy KM; Gibson GR; Fegeros K
    Anaerobe; 2006 Aug; 12(4):178-85. PubMed ID: 16731014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age.
    Walton GE; van den Heuvel EG; Kosters MH; Rastall RA; Tuohy KM; Gibson GR
    Br J Nutr; 2012 May; 107(10):1466-75. PubMed ID: 21910949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCR-ELISA II: Analysis of Bifidobacterium populations in human faecal samples from a consumption trial with Bifidobacterium lactis Bb-12 and a galacto-oligosaccharide preparation.
    Malinen E; Mättö J; Salmitie M; Alander M; Saarela M; Palva A
    Syst Appl Microbiol; 2002 Aug; 25(2):249-58. PubMed ID: 12353880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.
    Salazar N; Ruas-Madiedo P; Kolida S; Collins M; Rastall R; Gibson G; de Los Reyes-Gavilán CG
    Int J Food Microbiol; 2009 Nov; 135(3):260-7. PubMed ID: 19735956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fermentation properties and potential prebiotic activity of Bimuno® galacto-oligosaccharide (65 % galacto-oligosaccharide content) on in vitro gut microbiota parameters.
    Grimaldi R; Swann JR; Vulevic J; Gibson GR; Costabile A
    Br J Nutr; 2016 Aug; 116(3):480-6. PubMed ID: 27267934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp.
    Ba Z; Lee Y; Meng H; Kris-Etherton PM; Rogers CJ; Lewis ZT; Mills DA; Furumoto EJ; Rolon ML; Fleming JA; Roberts RF
    mSphere; 2021 Aug; 6(4):e0008421. PubMed ID: 34232082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Bifidobacterium thermophilum RBL67 and fructo-oligosaccharides on the gut microbiota in Göttingen minipigs.
    Tanner SA; Lacroix C; Del'Homme C; Jans C; Zihler Berner A; Bernalier-Donadille A; Chassard C
    Br J Nutr; 2015 Sep; 114(5):746-55. PubMed ID: 26313935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.